Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs. This report contains market size and forecasts of Erectile Dysfunction Treatment Drugs in global, including the following market information:
Global Erectile Dysfunction Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Erectile Dysfunction Treatment Drugs market was valued at US$ 4995.6 million in 2022 and is projected to reach US$ 6356.9 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
We surveyed the Erectile Dysfunction Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Global Erectile Dysfunction Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Erectile Dysfunction Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Erectile Dysfunction Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erectile Dysfunction Treatment Drugs, market overview.
Chapter 2: Global Erectile Dysfunction Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erectile Dysfunction Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Erectile Dysfunction Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erectile Dysfunction Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erectile Dysfunction Treatment Drugs Overall Market Size
2.1 Global Erectile Dysfunction Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Erectile Dysfunction Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Erectile Dysfunction Treatment Drugs Players in Global Market
3.2 Top Global Erectile Dysfunction Treatment Drugs Companies Ranked by Revenue
3.3 Global Erectile Dysfunction Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Erectile Dysfunction Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Erectile Dysfunction Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Erectile Dysfunction Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Erectile Dysfunction Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Phosphodiesterase Type 5 Inhibitors
4.1.3 Prostaglandin E1
4.2 By Type - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Erectile Dysfunction Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Erectile Dysfunction Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.3.2 US Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.3 France Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.5.2 China Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.6 India Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
7 Erectile Dysfunction Treatment Drugs Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.1.4 Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Dong-A Pharmaceutical Co. Ltd
7.2.1 Dong-A Pharmaceutical Co. Ltd Company Summary
7.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
7.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Major Product Offerings
7.2.4 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Dong-A Pharmaceutical Co. Ltd Key News & Latest Developments
7.3 Vivus, Inc.
7.3.1 Vivus, Inc. Company Summary
7.3.2 Vivus, Inc. Business Overview
7.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.3.4 Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Vivus, Inc. Key News & Latest Developments
7.4 Meda Pharmaceuticals
7.4.1 Meda Pharmaceuticals Company Summary
7.4.2 Meda Pharmaceuticals Business Overview
7.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Major Product Offerings
7.4.4 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Meda Pharmaceuticals Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Major Product Offerings
7.5.4 Bayer AG Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer AG Key News & Latest Developments
7.6 Johnson & Johnson Services
7.6.1 Johnson & Johnson Services Company Summary
7.6.2 Johnson & Johnson Services Business Overview
7.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Major Product Offerings
7.6.4 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Services Key News & Latest Developments
7.7 Apricus Biosciences
7.7.1 Apricus Biosciences Company Summary
7.7.2 Apricus Biosciences Business Overview
7.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Major Product Offerings
7.7.4 Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Apricus Biosciences Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Major Product Offerings
7.8.4 Eli Lilly Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Erectile Dysfunction Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Erectile Dysfunction Treatment Drugs Market Drivers in Global Market
Table 3. Erectile Dysfunction Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Erectile Dysfunction Treatment Drugs in Global Market
Table 5. Top Erectile Dysfunction Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Erectile Dysfunction Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Erectile Dysfunction Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Erectile Dysfunction Treatment Drugs Product Type
Table 9. List of Global Tier 1 Erectile Dysfunction Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Erectile Dysfunction Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Erectile Dysfunction Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Erectile Dysfunction Treatment Drugs Product Offerings
Table 32. Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Dong-A Pharmaceutical Co. Ltd Company Summary
Table 35. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Product Offerings
Table 36. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Dong-A Pharmaceutical Co. Ltd Key News & Latest Developments
Table 38. Vivus, Inc. Company Summary
Table 39. Vivus, Inc. Erectile Dysfunction Treatment Drugs Product Offerings
Table 40. Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Vivus, Inc. Key News & Latest Developments
Table 42. Meda Pharmaceuticals Company Summary
Table 43. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Product Offerings
Table 44. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Meda Pharmaceuticals Key News & Latest Developments
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Erectile Dysfunction Treatment Drugs Product Offerings
Table 48. Bayer AG Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Johnson & Johnson Services Company Summary
Table 51. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Product Offerings
Table 52. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Services Key News & Latest Developments
Table 54. Apricus Biosciences Company Summary
Table 55. Apricus Biosciences Erectile Dysfunction Treatment Drugs Product Offerings
Table 56. Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Apricus Biosciences Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Erectile Dysfunction Treatment Drugs Product Offerings
Table 60. Eli Lilly Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Erectile Dysfunction Treatment Drugs Segment by Type in 2022
Figure 2. Erectile Dysfunction Treatment Drugs Segment by Application in 2022
Figure 3. Global Erectile Dysfunction Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Erectile Dysfunction Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Erectile Dysfunction Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer AG Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
